The OPALS Major Trauma Study: impact of advanced life-support on survival and morbidity

Stiell, Ian G.; Nesbitt, Lisa P.; Pickett, William; Munkley, Douglas; Spaite, Daniel W.; Banek, Jane; Field, Brian; Luinstra-Toohey, Lorraine; Maloney, Justin; Dreyer, Jon; Lyver, Marion; Campeau, Tony; Wells, George A.
April 2008
CMAJ: Canadian Medical Association Journal;4/22/2008, Vol. 178 Issue 9, p1141
Academic Journal
Background: To date, the benefit of prehospital advanced life-support programs on trauma-related mortality and morbidity has not been established Methods: The Ontario Prehospital Advanced Life Support (OPALS) Major Trauma Study was a before-after systemwide controlled clinical trial conducted in 17 cities. We enrolled adult patients who had experienced major trauma in a basic life-support phase and a subsequent advanced life-support phase (during which paramedics were able to perform endotracheal intubation and administer fluids and drugs intravenously). The primary outcome was survival to hospital discharge. Results: Among the 2867 patients enrolled in the basic lifesupport (n = 1373) and advanced life-support (n = 1494) phases, characteristics were similar, including mean age (44.8 v. 47.5 years), frequency of blunt injury (92.0% v. 91.4%), median injury severity score (24 v. 22) and percentage of patients with Glasgow Coma Scale score less than 9 (27.2% v. 22.1%). Survival did not differ overall (81.1% among patients in the advanced life-support phase v. 81.8% among those in the basic life-support phase; p = 0.65). Among patients with Glasgow Coma Scale score less than 9, survival was lower among those in the advanced life-support phase (50.9% v. 60.0%; p = 0.02). The adjusted odds of death for the advanced life-support v. basic life-support phases were nonsignificant (1.2, 95% confidence interval 0.9-1.7; p = 0.16). Interpretation: The OPALS Major Trauma Study showed that systemwide implementation of full advanced life-support programs did not decrease mortality or morbidity for major trauma patients. We also found that during the advanced lifesupport phase, mortality was greater among patients with Glasgow Coma Scale scores less than 9. We believe that emergency medical services should carefully re-evaluate the indications for and application of prehospital advanced life-support measures for patients who have experienced major trauma.


Related Articles

  • Assessing the Ethics of Medical Research in Emergency Settings: How Do International Regulations Work in Practice? Halila, Ritva // Science & Engineering Ethics;Sep2007, Vol. 13 Issue 3, p305 

    Different ethical principles conflict in research conducted in emergency research. Clinical care and its development should be based on research. Patients in critical clinical condition are in the greatest need of better medicines. The critical condition of the patient and the absence of a...

  • Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction. McMurray, John J. V. // Heart;Jul2001, Vol. 86 Issue 1, p97 

    Two landmark clinical trials, CONSENSUS I and SOLVD-T, have shown, unequivocally, that angiotensin converting enzyme (ACE) inhibitors reduce all cause mortality in patients with chronic heart failure and underlying left ventricular systolic dysfunction. A number of other key randomized,...

  • Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. Williams, D. S. // Journal of Insurance Medicine;2006, Vol. 38 Issue 4, p309 

    The article "Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability," from a 2006 issue of "JAMA," is reviewed.

  • The Research Process: Essential for Cures.  // AUANews;Fall/Winter2010 Urology Health Exta, p9 

    The article offers information of research as a process and its phases, including basic, translational and clinical. It relates the role of research in the development of treatments and preventive approaches to diseases. Basic research involves laboratory studies which allow researchers to gain...

  • ENHANCE: Imaging study did not show clinical benefit. Raible, Eric // Cardiology Today;Feb2008, Vol. 11 Issue 2, p19 

    The article provides information on the initial result of the Effect of Combination Ezetimibe and High-Dose Simvastatin versus Simvastatin Alone on Patients with Heterozygous Familial Hypercholesterolemia (ENHANCE) clinical trial. Result shows that ezetimibe drug failed to reduce the risk of...

  • Caution on Head Injury Rx. Stephenson, Joan // JAMA: Journal of the American Medical Association;11/17/2004, Vol. 292 Issue 19, p2329 

    States the current treatment of severe head injuries with corticosteroids is dangerous, according to an international study. Finding of increased mortality within two weeks of hospital admission; Rationale for the treatment; Details of the CRASH trial which gave patients methylprednisolone or a...

  • Proper interpretation and analysis of censored events and studies that contain them. Piantadosi, Steven // Multiple Sclerosis (13524585);Dec2005, Vol. 11 Issue 6, p624 

    Comments on the issues concerning the proper analysis of clinical trials involving patient with multiple sclerosis. Statistical distinction between patients; Data values required for survival analysis; Ways to assess the impact of the simple censoring assumption for lost to follow-up observations.

  • Management of toxic epidermal necrolysis and related syndromes. Mukasa, Y; Craven, N // Postgraduate Medical Journal;Feb2008, Vol. 84 Issue 988, p60 

    Toxic epidermal necrolysis and Stevens-Johnson syndrome are rare and life-threatening diseases that often configure as medical emergencies. The majority of cases are drug reactions. The clinical picture is one of widespread epidermal necrosis and mucosal erosions. Treatment is largely supportive...

  • The Early Treatment for Retinopathy of Prematurity Clinical Trial: presentation by subgroups versus analysis within subgroups. Hardy, R. J.; Good, W. V.; Dobson, V.; Palmer, E. A.; Tung, B.; Phelps, D. L.; Shapiro, M. J.; Van Heuven, W. A. J. // British Journal of Ophthalmology;Nov2006, Vol. 90 Issue 11, p1341 

    The article reflects on the results of the Early Treatment for Retinopathy of Prematurity Clinical Trial. Subgroup results have been presented, and the author comments that results have strengthened the confidence in the use of the clinical trial and help to shape individual clinical judgement...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics